Ischemic Heart Disease
📧 Sign up to get email alerts when something new happens for Ischemic Heart Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-01-17FDA Approved: LEXISCAN — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for LEXISCAN (regadenoson) submitted by Astellas Pharma US, Inc., expanding its regulatory use as a …
-
CLINICAL_TRIALS research · 2016-12-13Clinical Trial Update: Effect of Radiofrequency Ablation in Patients With Ventricular Arrhythmia Undergoing CABG [NA]
This clinical trial update examines the potential use of radiofrequency ablation to treat ventricular arrhythmias in patients undergoing cor…
-
CLINICAL_TRIALS research · 2016-12-06Clinical Trial Update: Epicardial Fat Pads Ablation During Coronary Surgery [Phase 2]
This entry reports a Phase 2 clinical trial evaluating epicardial fat pad ablation during coronary surgery for patients with atrial fibrilla…
-
CLINICAL_TRIALS research · 2016-12-05Clinical Trial Update: The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation [Phase 2]
Phase 2 clinical trial evaluating a botulinum toxin–containing pharmaceutical composition for atrial fibrillation; ischemic heart disease li…
-
CLINICAL_TRIALS trial_result · 2016-11-22Clinical Trial Update: Prevention of Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions [NA]
A completed clinical trial evaluating strategies to prevent contrast-induced nephropathy in patients with chronic kidney disease undergoing …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Efficacy Study of Paclitaxel-eluting Balloon, -Stent vs. Plain Angioplasty for Drug-eluting Stent Restenosis [Phase 4]
Phase 4 efficacy study comparing paclitaxel-eluting balloon and paclitaxel-eluting stent versus plain angioplasty for restenosis after drug-…
-
CLINICAL_TRIALS research · 2016-11-21Clinical Trial Update: Hyperbaric Oxygen Therapy in Patients With Chronic Stable Ischemic Heart Disease: An Option for Therapeutic Angiogenesis? [NA]
Clinical trial update exploring hyperbaric oxygen therapy as a potential option for therapeutic angiogenesis in patients with ischemic heart…
-
CLINICAL_TRIALS withdrawal · 2016-11-16Clinical Trial Update: Lower Leg Remote Ischemic Preconditioning in Elective Percutaneous Coronary Intervention (PCI)
A clinical trial evaluating lower-leg remote ischemic preconditioning during elective percutaneous coronary intervention has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Effect of Isoflurane on Tissue Doppler Imaging of Mitral Annulus During Cardiac Surgery [NA]
A completed clinical trial evaluated the effect of isoflurane anesthesia on tissue Doppler imaging of the mitral annulus during cardiac surg…
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: Exploration of Cerebral Pathophysiology During and After CABG Using CPB
Completed clinical trial investigating cerebral pathophysiology during and after coronary artery bypass grafting using cardiopulmonary bypas…
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: Narrow QRS Ischemic Patients Treated With Cardiac Resynchronization Therapy (NARROW CRT) [NA]
This update documents the NARROW CRT trial evaluating cardiac resynchronization therapy in narrow QRS ischemic heart failure patients and no…
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Verapamil vs Heparin in Transradial Procedures [Phase 4]
Phase 4 trial comparing verapamil versus heparin in transradial procedures has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-03Clinical Trial Update: Cardiac Magnetic Resonance Utilities in the Evaluation of Ischemic Heart Disease
A completed clinical trial evaluating the utility of cardiac magnetic resonance imaging in the evaluation of ischemic heart disease.
-
CLINICAL_TRIALS withdrawal · 2016-09-20Clinical Trial Update: An Efficacy and Safety Study for Nesiritide in Heart Failure Patients With Reduced Kidney Function Undergoing Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass (CPB Pump or Heart Lung Machine) [Phase 3]
A Phase 3 trial evaluating nesiritide in heart failure patients with reduced kidney function undergoing coronary artery bypass graft surgery…
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Coronary Artery Bypass Surgery (CABG) Off or On Pump Revascularization Study [Phase 3]
A Phase 3 trial comparing off-pump and on-pump coronary artery bypass grafting has completed.
-
FDA approval · 2016-09-02FDA Approved: NITROGLYCERIN — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for Nitroglycerin submitted by Prasco Laboratories, granting regulatory approval for this produc…
-
FDA approval · 2016-08-29FDA Approved: NITROSTAT — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Nitrostat (nitroglycerin) filed by Viatris Specialty LLC.
-
FDA approval · 2016-08-22FDA Approved: NITROGLYCERIN IN DEXTROSE — Supplemental Application (Baxter Healthcare Company)
FDA approved a supplemental application for NITROGLYCERIN IN DEXTROSE by Baxter Healthcare Company, indicating regulatory approval and label…
-
CLINICAL_TRIALS trial_result · 2016-08-18Clinical Trial Update: The Health Impact of High Intensity Exercise Training With Intervals During Cardiac Rehabilitation [NA]
This completed clinical trial evaluated the health impact of high-intensity interval training during cardiac rehabilitation. The study statu…
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: Telemonitoring During Phase 2-3 Cardiac Rehabilitation [Phase 2]
A Phase 2 trial evaluating telemonitoring during cardiac rehabilitation for ischemic heart disease has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: Which Platelet Function Test Best Reflects the In Vivo Plasma Concentrations of Ticagrelor and Its Active Metabolite?
A completed clinical trial assessed which platelet function test best reflects the in vivo plasma concentrations of ticagrelor and its activ…
-
CLINICAL_TRIALS trial_result · 2016-08-11Clinical Trial Update: The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease [Phase 3]
This document reports the completion status of the Phase 3 CLARICOR trial evaluating whether clarithromycin affects mortality and morbidity …
-
FDA approval · 2016-08-11FDA Approved: BRILINTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Brilinta (ticagrelor) from AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Beta-Blocker Heart Attack Trial (BHAT) [Phase 3]
This update reports the completion of the Phase 3 Beta-Blocker Heart Attack Trial (BHAT), a study of beta-blocker therapy in patients after …
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART) [Phase 3]
A phase 3 clinical trial (WELL-HART) evaluating estrogen/progestin therapy for lipid lowering and regression of atherosclerosis has complete…